Abstract Utilizing BRAF V600E mutation as a marker may reduce unnecessary prophylactic
central neck dissection (pCND) in clinically nodal negative (cN0) neck for small (≤ 2 cm) …

Background The necessity of prophylactic central neck dissection is one of debating issues
in the treatment of papillary thyroid carcinoma (PTC). In a previous study, the predictive …

Context: Few reports have determined whether preoperative detection of the BRAF V600E
mutation in fine-needle aspiration biopsy (FNAB) may influence determination of surgical …

Background BRAF V600E mutation is correlated with local aggressive clinicopathological
features in papillary thyroid carcinoma; yet the relationship between this genetic variation …

Introduction Thyroid cancer is the most prevalent endocrine malignancy, with its global
incidence increasing annually in recent years. Papillary carcinoma is the most common …

Background: Studies have demonstrated an association of the BRAFV600E mutation and
microRNA (miR) expression with aggressive clinicopathologic features in papillary thyroid …

Purpose This study was designed to examine whether available preoperative clinical
parameters, including B-type Raf kinase (BRAF) V600E mutation status, can identify patients …

Background. The BRAF V600E mutation is an important genetic event in papillary thyroid
cancer (PTC). This study aimed to provide additional information regarding the association …

Background: There is conflicting literature regarding the association of the BRAF V600E
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …

Context: Evaluation of the degree of neoplastic infiltration beyond the thyroid capsule
remains a unique parameter that can be evaluated by histopathological examination to label …